1. Home
  2. Analysis
  3. Systemic-lupus-erythematosus
  4. Maternal-condition-affecting-foetus

Systemic lupus erythematosus and Maternal condition affecting foetus

Summary:

Maternal condition affecting foetus is found among people with Systemic lupus erythematosus, especially for people who are female, 30-39 old.

The study analyzes which people have Maternal condition affecting foetus with Systemic lupus erythematosus. It is created by eHealthMe based on reports of 12 people who have Systemic lupus erythematosus from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Systemic lupus erythematosus?

Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 1,088 drugs and 1,644 conditions by eHealthMe. Check the latest studies of Systemic lupus erythematosus.

What is Maternal condition affecting foetus?

Maternal condition affecting foetus (mother condition affecting baby) is found to be associated with 28 drugs and 114 conditions by eHealthMe. Check the latest studies of Maternal condition affecting foetus.

On Aug, 02, 2026

12 people who have Systemic Lupus Erythematosus and Maternal Condition Affecting Foetus are studied.

Would you have Maternal condition affecting foetus when you have Systemic lupus erythematosus?

Gender of people who have Systemic Lupus Erythematosus and experienced Maternal Condition Affecting Foetus *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Systemic Lupus Erythematosus and experienced Maternal Condition Affecting Foetus *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 100 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 1 person, 8.33%

Common drugs taken by these people *:

  1. Prednisolone: 11 people, 91.67%
  2. Mupirocin: 11 people, 91.67%
  3. Methylprednisolone: 11 people, 91.67%
  4. Lactulose: 11 people, 91.67%
  5. Azathioprine: 11 people, 91.67%
  6. Senna: 10 people, 83.33%
  7. Folic Acid: 10 people, 83.33%
  8. Chlorhexidine Gluconate: 10 people, 83.33%
  9. Hydroxychloroquine Sulfate: 5 people, 41.67%
  10. Alendronic Acid: 5 people, 41.67%

Common symptoms for these people *:

  1. Death: 2 people, 16.67%
  2. Pregnancy On Contraceptive: 1 person, 8.33%
  3. Maternal Exposure During Pregnancy (use of substance during pregnancy): 1 person, 8.33%
  4. Drug Exposure During Pregnancy: 1 person, 8.33%
  5. Complication Of Pregnancy: 1 person, 8.33%
  6. Abortion Spontaneous (naturally occurring miscarriage): 1 person, 8.33%
  7. Abortion Induced (medically referred abortion): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Maternal condition affecting foetus?

- Check whether Maternal condition affecting foetus is associated with a drug or a condition

Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Maternal condition affecting foetus:

All the conditions that are associated with Maternal condition affecting foetus:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Maternal condition affecting foetus and Systemic lupus erythematosus, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.